Researchers Fishing Pure Gold from Seawater
- Chemistry
- May 16, 2016
Plasmodium vivax, which causes 16 million cases of malaria each year worldwide, takes thousands of years adapting to the local circumstances, an adaptive capacity that make this parasite a challenge seeking vaccines and drugs to combat malaria.
READ MORETatD-like DNase is an essential factor for the survival of malarial parasites in the host and is a potential malaria vaccine candidate.
READ MOREAn international team of researchers has found similar molecules to heparin, isolated from sea cucumbers, red algae and marine sponges, which inhibit the growth of Plasmodium falciparum, one of the parasites that cause malaria. Unlike heparin, these molecules have reduced anticoagulant activity as blood, opening new avenues for the development of antimalarial drugs.
READ MOREThe cases of the mosquito-borne disease amount to some 214 million people worldwide.
READ MOREResearchers reveal that the drug was discontinued before.
READ MORE